Contact lens suitable for those with allergies

Article

Switching patients to 1-day disposable contact lenses (CLs) may improve lens-wearing comfort for those who have seasonal allergic conjunctivitis, according to CooperVision.

Key Points

Fairport, NY-Switching patients to 1-day disposable contact lenses (CLs) may improve lens-wearing comfort for those who have seasonal allergic conjunctivitis, according to CooperVision. Wearing new lenses each day means that allergens have less time to build up on the lens surface, minimizing allergic response.

"The two best options for CL wearers who experience allergic reactions and would like to continue wearing their contacts during those times are pharmacological therapy and the utilization of 1-day disposable lenses," said Harvard Sylvan, OD, director of professional relations for CooperVision.

"As lens dehydration and protein deposition can occur during the course of the day even with daily disposables, a material that resists both deposits and dehydration is preferable," Dr. Sylvan added.

Recent Videos
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Bonnie An Henderson in an interview for the EnVision Summit
© 2025 MJH Life Sciences

All rights reserved.